This story describes a medical research protocol that will determine whether patients with heart attacks and congestive heart failure can be helped with their own bone marrow stem cells. The difference between stem cell treatments and existing therapies is profound: “The potential new benefit from stem cell therapy is the ability to prevent [heart] muscle loss, whereas other options compensate for muscle loss.” In other words, if the stem cell therapy works, the patient will literally be better biologically, whereas the heart drugs for the condition currently in use seek to circumvent and overcome the dysfunction caused by underlying disease.
YOU MIGHT ALSO LIKE
The Church in the Age of Therapy
In 1966, Philip Rieff wrote in The Triumph of the Therapeutic that “Religious man was born to…
Canada’s Deadliest Blind Spot
On September 20, the Daily Mail ran a story with the provocative headline, “Our 83-year-old Christian grandmother…
The Faithful Joy of Dolly Parton and Fulton Sheen
Dolly Parton and Fulton Sheen seem to have had little in common. She favored rhinestones; he wore…
